ARCON denounces the mismanagement of cancer in Nigeria
The President of the Association of Radiation and Clinical Oncologist of Nigeria (ARCON), Dr. Nwamaka Lasebikan, has sounded the alarm over the rising incidence of cancer and poor treatment outcomes in the country.
Dr Lasebikan was speaking at the just-concluded one-day symposium on the theme: “Optimizing the Standard of Care for Breast Cancer in Nigeria” in Enugu State.
According to her, even with treatment, the results are poor and she attributes this in part to the misuse of evidence-based standardized treatment options.
She emphasized the need to close the care gap and generally improve both quality of life and clinical outcomes for breast cancer patients through widespread adoption and implementation. of the harmonized guideline to ensure breast cancer care is optimal and standardized in Nigeria and Africa. in general.
Responding, the Consultant/Associate Director of the National Cancer Control Programme, Dr Uchechukwu Nwokwu, who represented the Minister of Health, reaffirmed the Government’s commitment to ensuring adequate access to standardized cancer care in the countries through programs such as the ongoing Cancer Health Funds, Cancer Access Policy and Chemotherapy Safety.
He spoke about the need for the federal government to adopt the National Comprehensive Cancer Network (NCCN) harmonized guidelines and the need for healthcare workers to adhere to them.
The speakers present at the symposium were; the Minister of Health represented by Dr Uchechukwu Emmanuel Nwokwu, Enugu State Health Commissioner, Dr Ikechukwu Obi, National Chairman of the Nigerian Medical Association (NMA) represented by the President of the Section of the State of Enugu, Dr Tony Onyia.
The others are the Chief Medical Director of Teaching Hospital (UNTH) represented by Prof Val Ugwu, Medical Women Association of Nigeria (MWAN) Enugu State Chapter Dr Ijeoma Obianyo, Consultant Radiologist, Prof Ifeoma Okoye, President Elect, West African College of Surgeons Prof. Emmanuel Ezeome among other oncology professors and consultants.
The symposium included several lectures from seasoned oncology experts on topics such as “Standardizing Breast Cancer Care through Adherence to Guidelines”.
Some predictive and prognostic biomarkers in decision-making for breast cancer were highlighted and there were also panel discussions by the UNTH Oncology Center on how to maximize the team approach multidisciplinary using a selected case presented.
Other symposium activities also included a session that engaged all attendees to identify barriers and explore solutions to low compliance with NCCN Harmonized Guidelines.